A Patient with Crohn Disease Will Receive an Initial Infusion

A patient with Crohn disease will receive an initial infusion of infliximab. The prescriber explains how this drug works to treat this disease. Which statement by the patient indicates a need for further teaching?

A) "I may have an increased risk of infections when taking infliximab."
B) "I should report chills, fever, itching, and shortness of breath while receiving the infusion."
C) "This drug sometimes provides a complete cure of inflammatory bowel disease."
D) "I will take the second dose in 2 weeks, the third dose in 6 weeks, and then a dose every 8 weeks thereafter."